anmelden
SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 26.10.22 | Novartis Underperform | Credit Suisse Group | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.22 | Novartis Underweight | Barclays Capital | |
| 25.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Sell | Deutsche Bank AG | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
| 24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.22 | Roche Hold | Deutsche Bank AG | |
| 19.10.22 | Roche Outperform | Credit Suisse Group | |
| 19.10.22 | Roche Overweight | Barclays Capital | |
| 18.10.22 | Roche Neutral | UBS AG | |
| 18.10.22 | Roche Buy | Jefferies & Company Inc. | |
| 18.10.22 | Roche Outperform | Bernstein Research | |
| 18.10.22 | Roche Overweight | Barclays Capital | |
| 18.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.10.22 | Roche Outperform | Credit Suisse Group | |
| 14.10.22 | Novartis Underweight | Barclays Capital | |
| 11.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.10.22 | Roche Hold | Deutsche Bank AG | |
| 07.10.22 | Novartis Sell | Deutsche Bank AG | |
| 05.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.22 | Roche Hold | Deutsche Bank AG | |
| 04.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.09.22 | Roche Neutral | UBS AG | |
| 29.09.22 | Roche Hold | Deutsche Bank AG | |
| 29.09.22 | Roche Overweight | Barclays Capital | |
| 28.09.22 | Roche Hold | Deutsche Bank AG | |
| 26.09.22 | Novartis Neutral | UBS AG | |
| 23.09.22 | Novartis Sell | Deutsche Bank AG | |
| 23.09.22 | Novartis Underweight | Barclays Capital | |
| 23.09.22 | Novartis Underperform | Credit Suisse Group | |
| 23.09.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.09.22 | Novartis Underweight | JP Morgan Chase & Co. |